Nano-X Imaging Ltd. (NNOX)
NASDAQ: NNOX · Real-Time Price · USD
4.130
-0.230 (-5.28%)
At close: Nov 24, 2025, 4:00 PM EST
4.179
+0.049 (1.19%)
After-hours: Nov 24, 2025, 7:59 PM EST
Nano-X Imaging Revenue
Nano-X Imaging had revenue of $3.45M in the quarter ending September 30, 2025, with 13.72% growth. This brings the company's revenue in the last twelve months to $12.30M, up 15.19% year-over-year. In the year 2024, Nano-X Imaging had annual revenue of $11.28M with 13.91% growth.
Revenue (ttm)
$12.30M
Revenue Growth
+15.19%
P/S Ratio
22.35
Revenue / Employee
$74,558
Employees
165
Market Cap
270.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.28M | 1.38M | 13.91% |
| Dec 31, 2023 | 9.91M | 1.33M | 15.47% |
| Dec 31, 2022 | 8.58M | 7.27M | 557.82% |
| Dec 31, 2021 | 1.30M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NNOX News
- 13 hours ago - Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals - GlobeNewsWire
- 22 hours ago - Nanox Announces $15 Million Registered Direct Offering of Common Stock - GlobeNewsWire
- 4 days ago - Nano-X Imaging Ltd. (NNOX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Vaso Corporation Announces Divestiture of Subsidiary - GlobeNewsWire
- 5 days ago - Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions - GlobeNewsWire
- 11 days ago - Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting - GlobeNewsWire
- 2 months ago - Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging - GlobeNewsWire
- 3 months ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga